Table 1.

Concentrations (ng/g lipid) of PBDE and HO-PBDE congeners in fetal and maternal blood and their percent of total measurable analytes.

	Fetal samples (n = 16)			Maternal samples (n = 4)			Combined samples ( n = 20)
Compound or congener	Mean ± SE	Median	% of total mean	Mean ± SE	Median	% of total mean	Mean ± SE	Median	% of total mean	Mice (n = 15)a % of total mean
PBDE congener
BDE-28	2.3 ± 1.0	0.8	1.9	0.5 ± 0.2	0.3	1.4	1.9 ± 0.8	0.7	1.9	0.2
BDE-47	70 ± 36	13	59	17 ± 5.1	15	49	60 ± 29	13	58	19
BDE-99	22 ± 11	5.3	18	6.3 ± 1.9	6.3	18	19 ± 8.6	5.3	18	20
BDE-100	12 ± 5.5	2.6	9.8	3.0 ± 0.3	3.0	8.7	9.9 ± 4.4	2.6	9.7	6.6
BDE-153	9.4 ± 4.1	2.7	8.0	6.7 ± 2.5	5.5	20	8.9 ± 3.2	3.8	8.7	54
BDE-154	4.6 ± 2.4	1.3	3.9	1.2 ± 0.1	1.2	3.6	3.8 ± 1.9	1.2	3.7	1.0
Total	120 ± 55	31		34 ± 8.5	34		100 ± 45	31
Phenolic metabolite
2,4-DBP	20 ± 12	4.7	21	1.5 ± 0.5	1.3	21	16 ± 9.6	3.5	21	15
2,4,5-TBP	7.9 ± 6.0	1.2	8.2	0.2 ± 0.03	0.2	3.6	6.4 ± 4.8	0.7	8.1	16
2,4,6-TBP	5.6 ± 1.3	5.1	5.7	0.8 ± 0.3	0.6	12	4.6 ± 1.1	3.0	5.9	1.1
4′-HO-BDE-17	ND	ND	ND	ND	ND	ND	ND	ND	ND	3.5
2′-HO-BDE-28	ND	ND	ND	ND	ND	ND	ND	ND	ND	2.3
4-HO-BDE-42	0.9 ± 0.3	ND	0.9	ND	ND	ND	0.9 ± 0.3	ND	1.1	38
3-HO-BDE-47	1.6 ± 1.1	0.4	1.7	0.1 ± 0.02	0.09	1.3	1.3 ± 0.8	0.3	1.6	11
5-HO-BDE-47	28 ± 16	5.7	29	1.6 ± 0.5	1.4	23	23 ± 13	4.2	29	ND
6-HO-BDE-47	9.9 ± 4.9	1.0	10	0.3 ± 0.1	0.2	3.9	7.9 ± 4.0	0.8	10	4.6
4′-HO-BDE-49	0.9 ± 0.2	ND	0.9	0.3 ± 0.06	0.3	3.5	0.7 ± 0.2	ND	0.8	8.7
5′-HO-BDE-99	22 ± 15	4.3	23	2.0 ± 0.6	1.7	28	18 ± 12	3.1	23	ND
6′-HO-BDE-99	1.9 ± 1.0	0.6	1.9	0.3 ± 0.04	0.3	3.7	1.5 ± 0.8	0.4	1.9	ND
Total	97 ± 55	22		7.0 ± 1.7	6.3		79 ± 44	19

ND, not detected.

^aData from Qiu et al. (2007).